title: Pregnant women with erythema migrans and isolation of borreliae from blood: course and outcome after treatment with ceftriaxone.
abstract: The course and outcome in 7 pregnant European women with erythema migrans and borreliae isolated from blood, treated with intravenous ceftriaxone for 14 days, were uneventful, and the outcome of their pregnancies was good. Spirochetemia was not associated with constitutional symptoms.
authors.affiliation: Department of Infectious Diseases, University Medical Center Ljubljana, 1525 Ljubljana, Slovenia. vera.maraspin@gmail.com
authors.forename: Vera
authors.initials: V
authors.lastname: Maraspin
authors.forename: Eva
authors.initials: E
authors.lastname: Ružić-Sabljić
authors.forename: Dušica
authors.initials: D
authors.lastname: Pleterski-Rigler
authors.forename: Franc
authors.initials: F
authors.lastname: Strle
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001769:Blood / Q000382:microbiology*; D015748:Borrelia burgdorferi Group / Q000302:isolation & purification*; D002443:Ceftriaxone / Q000008:administration & dosage*; D005060:Europe; D005260:Female; D005929:Glossitis, Benign Migratory / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D007262:Infusions, Intravenous; D008193:Lyme Disease / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D002443:Ceftriaxone